SAT-530 Differences In Perspectives Of Weight Management Among People In The US And Canada With T2D By BMI And Sex
Abstract Disclosure: M. Ross: Eli Lilly & Company. S. Mulnick: Eli Lilly & Company. K. Boye: Eli Lilly & Company. A. Samuelson: Eli Lilly & Company. V. Thieu: Eli Lilly & Company. C. Longuet: Eli Lilly & Company. J. Glass: Eli Lilly & Company. M. Hoog: Eli Lilly & Company. Background: Type 2 diabetes (T2D) affects approximately 35 million Americans and three million Canadians. The link between T2D and obesity has been well established and guidelines for treating T2D include recommendations to support patients in healthy weight reduction. This study explored the perspectives of people residing in the US and Canada with T2D across BMI categories regarding the perceived value of reaching a lower weight and how this would impact their lives. Methods: A quantitative cross-sectional survey informed by qualitative interviews was administered in English to adults in the US and Canada with T2D. Enrollment ensured a sample representative of the T2D population by BMI according to US census data. The survey explored weight management experience, impacts of T2D and weight on quality of life (QOL), and perceived value of 5%, 10%, and 20% weight reductions. Participants defined their dream, achievable, acceptable, and unsuccessful body weights, standardized as a proportion of their reported current weight. Results were summarized descriptively. Chi-square tests and t-tests assessed for significant differences between BMI categories and by sex at birth (p<0.05). Results: The 746 participants (US=388, Canada=358) were 45% female, 43% retired, and 77% college-educated or higher. Mean (SD) BMI was 32.8 kg/m2 (8.2) and was higher among female participants (female=35.0 kg/m2 (9.4); male=31.0 kg/m2 (6.5); p<0.001). 41% had a BMI<30 kg/m2 and 13% had a BMI<25 kg/m2. The majority (70%) self-reported an HbA1c <7%. Nearly all (93%) felt weight management was important to managing their T2D, regardless of BMI. Most (66%) reported currently trying to lose weight and thinking about trying to lose weight at least multiple times each week over the last 2 years, especially those with higher BMIs (p<0.001). A higher BMI was also associated with more impacts of weight on T2D (emotional well-being, medical/health complications, physical/mobility limitations, sleep, daily activities, social and financial). Participants with higher BMIs desired greater weight reduction than those with lower BMIs when defining their dream, achievable, acceptable and unsuccessful weight goals and were more likely to expect a positive and meaningful impact on their life with 5%, 10%, and 20% weight reductions. Statistical differences between male and female sex at birth were also observed, as female participants reported more impacts of weight on T2D, struggling to lose weight, and desiring greater weight reduction than male participants. Conclusion: Participants with T2D positively valued weight reduction and anticipate it to lead to improvements in their overall T2D management and QOL. As the percentage of weight reduction increased, those with higher BMIs and female participants perceived greater meaningfulness and more positive impacts. Presentation: Saturday, July 12, 2025
Authors
- Meredith M. Hoog (ORCID: https://orcid.org/0009-0000-1954-847X)
- Melissa Ross (ORCID: https://orcid.org/0000-0001-7317-9273)
- Jennifer M. Glass
- Kristina S. Boye (ORCID: https://orcid.org/0000-0002-5953-5929)
- Vivian T. Thieu (ORCID: https://orcid.org/0000-0001-9803-4134)
- Sarah Mulnick
- Ashley Samuelson
- Christine Longuet
Institutions
- Ithaka Harbors (US)
- Eli Lilly (United States) (US)
- Eli Lilly (Canada) (CA)
Publication Details
- Journal
- Journal of the Endocrine Society
- Published
- 2025-10-01
- DOI
- https://doi.org/10.1210/jendso/bvaf149.1062
- Primary Topic
- Obesity and Health Practices
- Type
- article
- Field-Weighted Citation Impact
- 0.00